TY - JOUR
T1 - Role of reactive oxygen species in acetylcholine-induced preconditioning in cardiomyocytes
AU - Yao, Zhenhai
AU - Tong, Jiankun
AU - Tan, Xiaohui
AU - Li, Changqing
AU - Shao, Zuohui
AU - Kim, Woo Chan
AU - Vanden Hoek, Terry L.
AU - Becker, Lance B.
AU - Head, C. Alvin
AU - Schumacker, Paul T.
N1 - Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.
PY - 1999/12
Y1 - 1999/12
N2 - We examined the ability of ACh to mimic ischemic preconditioning in cardiomyocytes and the role of ATP-sensitive potassium (K(ATP)) channels and mitochondrial reactive oxygen species (ROS) in mediating this effect. Chick embryonic ventricular myocytes were studied in a flow-through chamber while flow rate, pH, PO2, and PCO2 were controlled. Cell viability was quantified with propidium iodide (5 μM), and production of ROS was measured using 2',7'-dichlorofluorescin diacetate. Data were expressed as means ± SE. Preconditioning with 10 min of ischemia followed by 10 min of reoxygenation or 10 min of ACh (1 mM) followed by a drug-free period before 1 h of ischemia and 3 h of reoxygenation reduced cell death to the same extent [preconditioning 19 ± 2% (n = 6, P < 0.05) ACh 21 ± 5% (n = 6, P < 0.05) vs controls 42 ± 5% (n = 9)]. Like preconditioning, ACh increased ROS production threefold before ischemia [0.60 ± 0.16 (n = 7, P < 0.05) vs. controls, 0.16 ± 0.03 (n = 6); arbitrary units]. Protection and increased ROS production during ACh preconditioning were abolished with 5- hydroxydecanoate (5-HD, 100 μM), a selective mitochondrial K(ATP) channel antagonist, and the thiol reductant 2-mercaptopropionyl glycine (2-MPG, 1 mM), an antioxidant [cell death: 5-HD+ACh 37 ± 7% (n = 5), 2-MPG+ACh 47 ± 6% (n = 6); ROS signals: 5-HD+ACh 0.09 ± 0.03 (n = 5), 2-MPG+ACh 0.01 ± 0.04 (n = 4)]. In addition, ACh-induced ROS signaling was blocked by the mitochondrial site III electron transport inhibitor myxothiazol (0.02 ± 0.07, n = 5). These results demonstrate that activation of mitochondrial K(ATP) channels and increased ROS production from mitochondria are important intracellular signals that participate in ACh-induced preconditioning in cardiomyocytes.
AB - We examined the ability of ACh to mimic ischemic preconditioning in cardiomyocytes and the role of ATP-sensitive potassium (K(ATP)) channels and mitochondrial reactive oxygen species (ROS) in mediating this effect. Chick embryonic ventricular myocytes were studied in a flow-through chamber while flow rate, pH, PO2, and PCO2 were controlled. Cell viability was quantified with propidium iodide (5 μM), and production of ROS was measured using 2',7'-dichlorofluorescin diacetate. Data were expressed as means ± SE. Preconditioning with 10 min of ischemia followed by 10 min of reoxygenation or 10 min of ACh (1 mM) followed by a drug-free period before 1 h of ischemia and 3 h of reoxygenation reduced cell death to the same extent [preconditioning 19 ± 2% (n = 6, P < 0.05) ACh 21 ± 5% (n = 6, P < 0.05) vs controls 42 ± 5% (n = 9)]. Like preconditioning, ACh increased ROS production threefold before ischemia [0.60 ± 0.16 (n = 7, P < 0.05) vs. controls, 0.16 ± 0.03 (n = 6); arbitrary units]. Protection and increased ROS production during ACh preconditioning were abolished with 5- hydroxydecanoate (5-HD, 100 μM), a selective mitochondrial K(ATP) channel antagonist, and the thiol reductant 2-mercaptopropionyl glycine (2-MPG, 1 mM), an antioxidant [cell death: 5-HD+ACh 37 ± 7% (n = 5), 2-MPG+ACh 47 ± 6% (n = 6); ROS signals: 5-HD+ACh 0.09 ± 0.03 (n = 5), 2-MPG+ACh 0.01 ± 0.04 (n = 4)]. In addition, ACh-induced ROS signaling was blocked by the mitochondrial site III electron transport inhibitor myxothiazol (0.02 ± 0.07, n = 5). These results demonstrate that activation of mitochondrial K(ATP) channels and increased ROS production from mitochondria are important intracellular signals that participate in ACh-induced preconditioning in cardiomyocytes.
KW - Adenosine 5'-triphosphate-dependent potassium channels
KW - Mitochondria
KW - Reactive oxygen species
KW - Signal transduction
UR - http://www.scopus.com/inward/record.url?scp=17044457085&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=17044457085&partnerID=8YFLogxK
U2 - 10.1152/ajpheart.1999.277.6.h2504
DO - 10.1152/ajpheart.1999.277.6.h2504
M3 - Article
C2 - 10600875
AN - SCOPUS:17044457085
SN - 0363-6135
VL - 277
SP - H2504-H2509
JO - American Journal of Physiology
JF - American Journal of Physiology
IS - 6 46-6
ER -